mutations and complex kar yotype. It follows a linear evolution within the CLL clone through the recurrent acquisition of CDKN2ANot all people with CLL have to have therapy. Even with all current advances, the iwCLL continue to suggests watchful observation for patients with asymptomatic disorder.86 This recommendation is predicated on no less than